For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Latanoprost with timolol - Glaucoma / ocular hypertension
PAD Profile : Latanoprost with timolol - Glaucoma / ocular hypertension Important
Traffic Light Status
Status 1 of 2.
- Eye drops (preservative free)
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
- Latanoprost
- Bimatoprost
- Timolol
- Dorzolamide and timolol
- Brinzolamide
- Brimonidine tartrate
- Dorzolamide
- Acetazolamide
- Timolol and bimatoprost
- Timolol and brimonidine
- Brinzolamide/brimonidine
- Brinzolamide and timolol
- Tafluprost
- Travoprost
- Timolol and travoprost
- Pilocarpine hydrochloride
- Betaxolol
- Levobunolol hydrochloride
- Apraclonidine
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
Primary care prescribers do not have the necessary equipment or skills to perform ocular pressure readings to make a diagnosis. The APC recomments that this product, when used for treatment of glaucoma, should be considered as BLUE.
Preservative free eye drops:
The Surrey & North West Sussex Area Prescribing Committee recommends latanoprost/timolol preservative free eye drops as the first-line combination prostaglandin/beta-blocker eye drop where a preservative-free formulation is required, for the reduction of intraocular pressure in patients with Glaucoma and they will be considered BLUE (with no information sheet) on the traffic light system and at least 1 month supply should be supplied at initiation.
NB: Patients switching from separate components to the combination product can be switched by the primary care prescriber without the need to refer into an ophthalmologist for review. Primary care prescribers should be mindful of the strength of the timolol during rationalisation.